Friday, July 31, 2026

Biosimilar Red Tape Showdown: Patient Groups and Insurers Push Congress to End “Interchangeability” Rules After $56B in Savings

U.S. groups urge Congress to eliminate biosimilar interchangeability regulations, boosting access and reducing costs for Korean firms.

Tag: disparity

No posts to display

Top News

- Our Sponsors Ad -

Follow us